The document discusses India's immunization program, which began in 1978. It outlines key terms like immunity, immunization, vaccines, and herd immunity. It describes the national immunization schedule and strategies to reduce morbidity and mortality from vaccine-preventable diseases through vaccination. It also discusses monitoring systems and highlights the importance of maintaining the cold chain to ensure vaccine quality as the program aims to universally protect children from prevalent diseases.
Pulse Polio is an immunisation campaign established by the government of India to eliminate poliomyelitis (polio) in India by vaccinating all children under the age of five years against the polio virus.
Universal Immunization Programme (UIP), started in India in 1985.
Ministry of Health & Family Welfare provides several vaccines to infants, children & pregnant women through UIP.
Immunization is a process through which a person is made immune to an infectious disease.
Immunization is one of the best public health intervention to prevent morbidity as well as mortality. it also help in prevention of malnutrition in young children.still developing countries are trying hard to make it universal. in india lot of changes have taken place in the immunization schedule and number of newer vaccines have been incorporated. still the awareness as well as acceptability is not universal . this presentation is very basic and will help students as well as teachers. we all have to join hands to make it universal
Pulse Polio is an immunisation campaign established by the government of India to eliminate poliomyelitis (polio) in India by vaccinating all children under the age of five years against the polio virus.
Universal Immunization Programme (UIP), started in India in 1985.
Ministry of Health & Family Welfare provides several vaccines to infants, children & pregnant women through UIP.
Immunization is a process through which a person is made immune to an infectious disease.
Immunization is one of the best public health intervention to prevent morbidity as well as mortality. it also help in prevention of malnutrition in young children.still developing countries are trying hard to make it universal. in india lot of changes have taken place in the immunization schedule and number of newer vaccines have been incorporated. still the awareness as well as acceptability is not universal . this presentation is very basic and will help students as well as teachers. we all have to join hands to make it universal
Immunization is a process of protecting an individual from a disease through introduction of live attenuated, killed or organisms or antibodies in the individual system.
Immunization is the process of protecting an individual by active or passive method.
The immunizing agents are
Vaccines, Immunoglobulins and antisera
Why vaccination?
Prevention of deadly and debilitating diseases.
Keeps child from suffering through a preventable illness.
Less doctor visits
No hospitalization
National Leprosy Eradication Programme (NLEP)Kavya .
Chronic infectious disease caused by Mycobacterium leprae.
It usually affects the skin and peripheral nerves
Long incubation period generally 5-7 years.
Classified as paucibacillary or multibacillary
permanent disability
Timely diagnosis and treatment of cases
On 19 November 1985, GOI renamed EPI program, modifying the schedule as ‘Universal Immunization Program’ dedicated to the memory of Late Prime Minister Mrs Indira Gandhi.
UIP has two vital components: immunization of pregnant women against tetanus, and immunization of children
India is the highest TB burden country in the world & accounts for nearly 1/5th (20 per cent) of global burden of tuberculosis, 2/3rd of cases in SEAR. Every year approximately 1.8 million persons develop tuberculosis, of which about 0.8 million are new smear positive highly'- infectious cases.Annual risk of becoming infected with TB is 1.5 % and once infected there is 10 % life-time risk of developing TB disease
Brief and easily understandable description on measles along with images for undergraduate students. this presentation would help in picturising what measles is.
Immunization is a process of protecting an individual from a disease through introduction of live attenuated, killed or organisms or antibodies in the individual system.
Immunization is the process of protecting an individual by active or passive method.
The immunizing agents are
Vaccines, Immunoglobulins and antisera
Why vaccination?
Prevention of deadly and debilitating diseases.
Keeps child from suffering through a preventable illness.
Less doctor visits
No hospitalization
National Leprosy Eradication Programme (NLEP)Kavya .
Chronic infectious disease caused by Mycobacterium leprae.
It usually affects the skin and peripheral nerves
Long incubation period generally 5-7 years.
Classified as paucibacillary or multibacillary
permanent disability
Timely diagnosis and treatment of cases
On 19 November 1985, GOI renamed EPI program, modifying the schedule as ‘Universal Immunization Program’ dedicated to the memory of Late Prime Minister Mrs Indira Gandhi.
UIP has two vital components: immunization of pregnant women against tetanus, and immunization of children
India is the highest TB burden country in the world & accounts for nearly 1/5th (20 per cent) of global burden of tuberculosis, 2/3rd of cases in SEAR. Every year approximately 1.8 million persons develop tuberculosis, of which about 0.8 million are new smear positive highly'- infectious cases.Annual risk of becoming infected with TB is 1.5 % and once infected there is 10 % life-time risk of developing TB disease
Brief and easily understandable description on measles along with images for undergraduate students. this presentation would help in picturising what measles is.
Cold Chain The ‘cold chain’ is the system of transporting and storing vaccines at recommended temperature from the point of manufacture to the point of use. Manufacturer Distributor Vaccine Depots Provider office Client.
This is an immunology lecture for medical students. it helps student to understand the importance of immunization in clinical practice. resident doctors can also benefit immensely with this lecture.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. IMMUNIZATION: COMMON
TERMS
Immunity :
Resistance of a host to a specific agent, characterized
by measurable and protective surface or humoral
antibody and by cell mediated immune responses.
Immunization:
Process of inducing immunity by stimulating immune
system through antigens.
3. Vaccine:
A preparation of a weakened or killed pathogen, such
as a bacterium or virus, or of a portion of the
pathogen's structure that upon administration
stimulates antibody production or cellular immunity
against the pathogen but is incapable of causing
severe infection.
Vaccination:
Administration of antigenic material (the vaccine) to
produce immunity to a disease.
4. Ring immunization:
Vaccination of people in close contact with an
isolated infected patient.
Catch up rounds:
Additional effort besides routine immunization to
cover left outs
Mop-up rounds:
When the final pockets of polio virus transmission
have been identified through standard surveillance,
door-to-door immunization in high-risk districts.
5. HERD IMMUNITY?
Resistance to spread of infectious disease in a group
because of few susceptible members, making
transmission unlikely.
The immunologic status of a population, determined
by the ratio of resistant to susceptible members and
their distribution.
6.
7. MILESTONES IN IMMUNIZATION
PROGRAM IN INDIA
1978: EPI
1985: UIP, Measles vaccine added
1988: AEFI Surveillance
1990: Vitamin A
1992: CSSM
1995: Polio National Immunization days
1997: RCH-I
2005: RCH-II and NRHM
8. EARLY VACCINES:
•BCG , DPT & Typhoid
•OPV Added
•1985: Measles added & Typhoid
dropped
•TT for Pregant
•2006: Hepatitis B, second dose of
measles and Japanese Encephalitis
•2011, pentavalent vaccine
9. STRATEGIES
•Reduce Morbidity & mortality of
VPDs by Immunisation
•Ingenious vaccine production
•Cold chain establishment
•Phased Implementation & full
coverage by 1990
•Monitoring & evaluation
14. COLD CHAIN
• The ‘cold chain’ is the system
of transporting and storing vaccines at
recommended temperature from the
point of manufacture to the point of
use.
• The World Health Organization
(WHO) reported that in 2005,
nearly half of all vaccines were
in transit due to poor
Manufacturer
Distributor
Vaccine
Depots
Provider office
Client
16. 1.Walk in cold rooms(WIC)
At regional level
Storage up to 3 months
At district & PHC levels
Temp :- -15oc to -25oc
At PHC, used only for the
preparation of ice packs
2.Deep
freezers
17. 3.Ice lined
refrigerators(ILR)
Both at district and PHC
levels
Temp :- +2oc to +8oc
ILR’s are top opening,
can hold cold air inside
better than front
opening refrigerators
18. VACCINE
SENSITIVITY
• Sensitivity to HEAT
BCG
Varicella
MMR
MenC
Hepatitis B
DT and/or
aP/IPV/HIB
• Sensitivity to COLD
HepB and
combination
DTand/or
aP/IPV/HIB
Influenza
MenC
*MMR
*Varicella
*BCG
(*Freeze
MOST
SENSITIVE
Temperature must be recorded twice in a day with dial
thermometer
LEAST
SENSITIVE
20. Used for transport of vaccines
Fully frozen ice packs placed
at the bottom and sides
DPT, TT, DT should not be kept
in direct contact
1.Cold
boxes
Used to carry small
quantity of vaccines(16 to
20 vials)
For out of reach sessions
4 icepacks are used
2.Vaccine
carriers
21. 3.Day carriers
Used to carry very small quantities
of vaccines(6 to 8 vials)
For a near by session
2 icepacks are used
For only 2 hours period
22. Vaccine Vial Monitor(VVM)
VVM is a label containing heat
sensitive material that is placed on
a vaccine vial to register heat
exposure over time
Vaccine vial
monitor
26. CONCLUSION
• The Immunization program started in 1978 has
undergone various transition over the decades.
More & more vaccines are being added.
• But at its core it continues to have the same
objective. Protect the children against the most
prevalent and serious diseases through universal
coverage.
• A proper monitoring system is essential to realise
this objective.
• Quality of the vaccine is more important than
quantity as universal coverage without proper
immune response is a waste.